trial · primary record
Psilocybin (drug)
Psilocybin
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 83 |
| Primary completion | 2031-01-31 |
| Primary endpoint | Safety and adverse events (AEs) |
| Registry ID | NCT07227909 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:30.052Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07227909
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Psilocybin · compound